• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Providing patients with global cardiovascular risk information: is knowledge power?

作者信息

Ahmad Tariq, Mora Samia

出版信息

Arch Intern Med. 2010 Feb 8;170(3):227-8. doi: 10.1001/archinternmed.2009.502.

DOI:10.1001/archinternmed.2009.502
PMID:20142566
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2856346/
Abstract
摘要

相似文献

1
Providing patients with global cardiovascular risk information: is knowledge power?向患者提供全球心血管风险信息：知识就是力量吗？
Arch Intern Med. 2010 Feb 8;170(3):227-8. doi: 10.1001/archinternmed.2009.502.
2
The Preventive-Pill Paradox: How Shared Decision Making Could Increase Cardiovascular Morbidity and Mortality.预防性药物悖论：共同决策如何可能增加心血管疾病的发病率和死亡率。
Circulation. 2016 Nov 22;134(21):1599-1600. doi: 10.1161/CIRCULATIONAHA.116.025204.
3
What do the 2011 American Heart Association guidelines tell us about prevention of cardiovascular disease in women?2011 年美国心脏协会指南关于女性心血管疾病预防的建议是什么？
Clin Cardiol. 2011 Sep;34(9):520-3. doi: 10.1002/clc.20940.
4
[Recommendations for prevention and evidence-based medicine].[预防建议与循证医学]
Z Kardiol. 2005;94 Suppl 3:III/1-5. doi: 10.1007/s00392-005-1301-3.
5
How much and what type of physical activity is enough? What physicians should tell their patients.
Arch Intern Med. 2005 Nov 14;165(20):2324-5. doi: 10.1001/archinte.165.20.2324.
6
Risk factors: Low educational attainment linked to high CVD risk.
Nat Rev Cardiol. 2017 Aug;14(8):442. doi: 10.1038/nrcardio.2017.100. Epub 2017 Jun 29.
7
Incorporating Risk Stratification Into the Practice of Pediatric Preventive Cardiology.将风险分层纳入儿科预防心脏病学实践。
Can J Cardiol. 2020 Sep;36(9):1417-1428. doi: 10.1016/j.cjca.2020.06.025. Epub 2020 Jul 14.
8
Disease Prevention: The moving target of global cardiovascular health.
Nat Rev Cardiol. 2009 May;6(5):327-8. doi: 10.1038/nrcardio.2009.48.
9
[Polish forum for prevention guidelines on cardiovascular risk assessment].[波兰心血管风险评估预防指南论坛]
Kardiol Pol. 2007 Jan;65(1):100-4.
10
[Nutrition patient education in the prevention of cardiovascular diseases].[营养患者教育在心血管疾病预防中的作用]
Soins. 2006 Jan-Feb(702 Suppl):S9-12.

引用本文的文献

1
Knowledge of cardiovascular disease risk and exercise duration among asymptomatic sedentary male individuals participating in Islamic prayer (Salaah).参与伊斯兰祈祷（礼拜）的无症状久坐男性个体的心血管疾病风险与运动时长知识
BMC Sports Sci Med Rehabil. 2022 Apr 1;14(1):56. doi: 10.1186/s13102-022-00449-7.
2
Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program.缬沙坦对高血压和总体心血管风险的真实世界疗效：一项转化研究计划的综述与启示
Vasc Health Risk Manag. 2011;7:209-35. doi: 10.2147/VHRM.S9434. Epub 2011 Mar 31.
3
Long-term effects of carotid screening on patient outcomes and behaviors.颈动脉筛查对患者预后及行为的长期影响。
Arch Intern Med. 2011 Mar 28;171(6):589-91. doi: 10.1001/archinternmed.2011.90.

本文引用的文献

1
The effect of giving global coronary risk information to adults: a systematic review.向成年人提供全球冠心病风险信息的效果：一项系统评价。
Arch Intern Med. 2010 Feb 8;170(3):230-9. doi: 10.1001/archinternmed.2009.516.
2
Calorie labeling and food choices: a first look at the effects on low-income people in New York City.卡路里标注与食品选择：对纽约市低收入人群影响的初步观察。
Health Aff (Millwood). 2009 Nov-Dec;28(6):w1110-21. doi: 10.1377/hlthaff.28.6.w1110. Epub 2009 Oct 6.
3
General cardiovascular risk profile for use in primary care: the Framingham Heart Study.用于初级保健的一般心血管风险概况：弗雷明汉心脏研究
Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.
4
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.女性全球心血管风险评估改良算法的开发与验证：雷诺兹风险评分
JAMA. 2007 Feb 14;297(6):611-9. doi: 10.1001/jama.297.6.611.
5
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.欧洲致命性心血管疾病十年风险评估：SCORE项目
Eur Heart J. 2003 Jun;24(11):987-1003. doi: 10.1016/s0195-668x(03)00114-3.
6
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study.基于前瞻性心血管明斯特（PROCAM）研究10年随访结果计算急性冠脉事件风险的简易评分方案。
Circulation. 2002 Jan 22;105(3):310-5. doi: 10.1161/hc0302.102575.
7
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).国家胆固醇教育计划（NCEP）成人高血胆固醇检测、评估与治疗专家小组第三次报告（成人治疗小组第三次报告）执行摘要
JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486.
8
Genetic risk and behavioural change.遗传风险与行为改变。
BMJ. 2001 Apr 28;322(7293):1056-9. doi: 10.1136/bmj.322.7293.1056.
9
Prediction of coronary heart disease using risk factor categories.使用风险因素类别预测冠心病。
Circulation. 1998 May 12;97(18):1837-47. doi: 10.1161/01.cir.97.18.1837.
10
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 2. Clinical epidemiology: the conceptual basis for interpreting risk factors.
J Am Coll Cardiol. 1996 Apr;27(5):976-8. doi: 10.1016/0735-1097(96)87730-8.